Literature DB >> 24692687

Targeting tropomyosin-receptor kinase fused gene in cancer.

Yun Chen1, Sheng-Hong Tseng.   

Abstract

Tropomyosin-receptor kinase fused gene (TRK-fused gene, TFG) encodes a protein which is a conserved regulator of protein secretion that localizes in the endoplasmic reticulum exit sites and controls the export of materials from the endoplasmic reticulum. It is important for intracellular trafficking of protein secretion. TFG belongs to the systems which control cell size, and is involved in regulatory mechanisms of apoptosis and cell proliferation. The TFG fusion proteins have been found to play a role in oncogenesis, with the activity of TFG fusion proteins promoting tumor development. In addition, TFG alone has been demonstrated to function like an oncoprotein; however, there are contradictory data suggesting TFG might act as a tumor suppressor. In this article, we will review the functions and regulation of TFG, the TFG fusion proteins, and the role of TFG in tumorigenesis. Finally, the potential of targeting TFG in cancer treatment is discussed.

Entities:  

Keywords:  TRK-fused gene; cancer; fusion proteins; review; tumorigenesis

Mesh:

Substances:

Year:  2014        PMID: 24692687

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

Review 1.  COPII-mediated trafficking at the ER/ERGIC interface.

Authors:  Jennifer Peotter; William Kasberg; Iryna Pustova; Anjon Audhya
Journal:  Traffic       Date:  2019-05-30       Impact factor: 6.215

2.  TFG binds LC3C to regulate ULK1 localization and autophagosome formation.

Authors:  Francesca Nazio; Francesco Cecconi; Marianna Carinci; Beatrice Testa; Matteo Bordi; Giacomo Milletti; Massimo Bonora; Laura Antonucci; Caterina Ferraina; Marta Carro; Mukesh Kumar; Donatella Ceglie; Franziska Eck; Roberta Nardacci; Francois le Guerroué; Stefania Petrini; Maria E Soriano; Ignazio Caruana; Valentina Doria; Maria Manifava; Camille Peron; Matteo Lambrughi; Valeria Tiranti; Christian Behrends; Elena Papaleo; Paolo Pinton; Carlotta Giorgi; Nicholas T Ktistakis; Franco Locatelli
Journal:  EMBO J       Date:  2021-05-01       Impact factor: 11.598

3.  TRK-Fused Gene (TFG), a protein involved in protein secretion pathways, is an essential component of the antiviral innate immune response.

Authors:  Kashif Aziz Khan; Alexandre Marineau; Priscilla Doyon; Mariana Acevedo; Étienne Durette; Anne-Claude Gingras; Marc J Servant
Journal:  PLoS Pathog       Date:  2021-01-07       Impact factor: 6.823

Review 4.  Classic and Variants APLs, as Viewed from a Therapy Response.

Authors:  Marie-Claude Geoffroy; Hugues de Thé
Journal:  Cancers (Basel)       Date:  2020-04-14       Impact factor: 6.639

5.  Wnt-inducible Lrp6-APEX2 interacting proteins identify ESCRT machinery and Trk-fused gene as components of the Wnt signaling pathway.

Authors:  Gabriele Colozza; Yasaman Jami-Alahmadi; Alyssa Dsouza; Nydia Tejeda-Muñoz; Lauren V Albrecht; Eric A Sosa; James A Wohlschlegel; Edward M De Robertis
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.996

6.  Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma.

Authors:  Steven G Waguespack; Alexander Drilon; Jessica J Lin; Marcia S Brose; Ray McDermott; Mohammed Almubarak; Jessica Bauman; Michela Casanova; Anuradha Krishnamurthy; Shivaani Kummar; Serge Leyvraz; Do-Youn Oh; Keunchil Park; Davendra Sohal; Eric Sherman; Ricarda Norenberg; Josh D Silvertown; Nicoletta Brega; David S Hong; Maria E Cabanillas
Journal:  Eur J Endocrinol       Date:  2022-04-29       Impact factor: 6.558

7.  Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma.

Authors:  Clément Meiller; François Montagne; Theo Z Hirsch; Stefano Caruso; Julien de Wolf; Quentin Bayard; Jean-Baptiste Assié; Léa Meunier; Yuna Blum; Lisa Quetel; Laure Gibault; Ecaterina Pintilie; Cécile Badoual; Sarah Humez; Françoise Galateau-Sallé; Marie-Christine Copin; Eric Letouzé; Arnaud Scherpereel; Jessica Zucman-Rossi; Françoise Le Pimpec-Barthes; Marie-Claude Jaurand; Didier Jean
Journal:  Genome Med       Date:  2021-07-14       Impact factor: 11.117

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.